Safety of drug use in patients with a primary mitochondrial disease: An international Delphi‐based consensus

Clinical guidance is often sought when prescribing drugs for patients with primary mitochondrial disease. Theoretical considerations concerning drug safety in patients with mitochondrial disease may lead to unnecessary withholding of a drug in a situation of clinical need. The aim of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vries, Maaike C., Brown, David A., Allen, Mitchell E., Bindoff, Laurence, Gorman, Gráinne S., Karaa, Amel, Keshavan, Nandaki, Lamperti, Costanza, McFarland, Robert, Ng, Yi Shiau, O'Callaghan, Mar, Pitceathly, Robert D. S., Rahman, Shamima, Russel, Frans G. M., Varhaug, Kristin N., Schirris, Tom J. J., Mancuso, Michelangelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383489/
https://www.ncbi.nlm.nih.gov/pubmed/32030781
http://dx.doi.org/10.1002/jimd.12196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383489/
https://www.ncbi.nlm.nih.gov/pubmed/32030781
http://dx.doi.org/10.1002/jimd.12196

Ejemplares similares